Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
Last trade$10.53
Day change-$0.595 (-5.35%)
Day range$10.53 – $11.55
Volume1,683,857
Market cap$2.79B
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for CLBT.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for CLBT.
Recent news
Company coverage with links to the original publishers.
Cellebrite reported Q3 2026 results showing 20% year-over-year ARR growth to $528.5 million, driven by strong adoption of its new Genesis AI platform which generated $2 million in ARR in its first full quarter. The company plans to redomicile to the U.S. in 2027 to reduce procurement friction, though conversion uplift from its core Inseyets software is tapering off. Management expects 30% free cash flow margin for the full year as subscription revenue reaches 91% of sales.
Cellebrite DI Ltd. reported Q3 2026 earnings of $0.17 per share, matching consensus estimates, with revenues of $149.02 million exceeding expectations by 2.35%. However, the stock has declined 29.6% year-to-date versus the S&P 500's 11.3% gain. The company received a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market.
A2Z Cust2Mate Solutions Corp. reported a Q3 loss of $0.15 per share, in line with consensus estimates, while significantly beating revenue expectations at $10.93 million (39% above estimates). Despite strong revenue growth year-over-year, the company has underperformed the S&P 500 by 14.1% this year and carries a Zacks Rank #3 (Hold) rating with mixed estimate revisions.
Anterix (ATEX) reported a quarterly loss of $0.25 per share, beating consensus estimates of $0.45 loss, representing a 44.44% earnings surprise. Revenue came in at $1.96 million, slightly missing estimates. The stock has surged 270% since the beginning of 2026, significantly outperforming the S&P 500's 10.3% gain. Zacks assigned the stock a Hold rating (Rank #3) with mixed estimate revisions, suggesting near-term performance in line with the market.
BILL Holdings reported Q3 2026 earnings of $1.18 per share, beating consensus estimates of $0.98 by 20.41%, but revenues of $353.77 million missed expectations by 19.36%. The stock has underperformed the S&P 500 by 17.2% year-to-date and carries a Zacks Rank #3 (Hold) rating. The company's future performance will depend on management commentary and earnings estimate revisions.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.